Literature DB >> 25980906

Neuroimaging evidence of gray and white matter damage and clinical correlates in progressive supranuclear palsy.

Maria Cristina Piattella1, N Upadhyay, M Bologna, E Sbardella, F Tona, A Formica, N Petsas, A Berardelli, P Pantano.   

Abstract

To evaluate gray matter (GM) and white matter (WM) abnormalities and their clinical correlates in patients with progressive supranuclear palsy (PSP). Sixteen PSP patients and sixteen age-matched healthy subjects underwent a clinical evaluation and multimodal magnetic resonance imaging, including three-dimensional T1-weighted imaging and diffusion tensor imaging (DTI). Volumetric and DTI analyses were computed using SPM and FSL tools. PSP patients showed GM volume decrease, involving the frontal cortex, putamen, pallidum, thalamus and accumbens nucleus, cerebellum, and brainstem. Additionally, they had widespread changes in WM bundles, mainly affecting cerebellar peduncles, thalamic radiations, corticospinal tracts, corpus callosum, and longitudinal fasciculi. GM volumes did not correlate with WM abnormalities. DTI indices of WM damage, but not GM volumes, correlated with clinical scores of disease severity and cognitive impairment. The neurodegenerative changes that occur in PSP involve both GM and WM structures and develop concurrently though independently. WM damage in PSP correlates with clinical scores of disease severity and cognitive impairment, thus providing further insight into the pathophysiology of the disease.

Entities:  

Mesh:

Year:  2015        PMID: 25980906     DOI: 10.1007/s00415-015-7779-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  43 in total

1.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

2.  Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.

Authors:  N J Cordato; A J Duggins; G M Halliday; J G L Morris; C Pantelis
Journal:  Brain       Date:  2005-04-20       Impact factor: 13.501

3.  Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference.

Authors:  Stephen M Smith; Thomas E Nichols
Journal:  Neuroimage       Date:  2008-04-11       Impact factor: 6.556

4.  Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy.

Authors:  A Padovani; B Borroni; S M Brambati; C Agosti; M Broli; R Alonso; P Scifo; G Bellelli; A Alberici; R Gasparotti; D Perani
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11-23       Impact factor: 10.154

5.  Clinical correlates of white matter tract degeneration in progressive supranuclear palsy.

Authors:  Jennifer L Whitwell; Ankit V Master; Ramesh Avula; Kejal Kantarci; Scott D Eggers; Heidi A Edmonson; Clifford R Jack; Keith A Josephs
Journal:  Arch Neurol       Date:  2011-06

6.  A clinical rating scale for progressive supranuclear palsy.

Authors:  Lawrence I Golbe; Pamela A Ohman-Strickland
Journal:  Brain       Date:  2007-04-02       Impact factor: 13.501

7.  Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias.

Authors:  O L Lopez; I Litvan; K E Catt; R Stowe; W Klunk; D I Kaufer; J T Becker; S T DeKosky
Journal:  Neurology       Date:  1999-10-12       Impact factor: 9.910

8.  Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.

Authors:  Adam L Boxer; Michael D Geschwind; Nataliya Belfor; Maria Luisa Gorno-Tempini; Guido F Schauer; Bruce L Miller; Michael W Weiner; Howard J Rosen
Journal:  Arch Neurol       Date:  2006-01

9.  Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy.

Authors:  Jae-Hyeok Lee; Yong-Hee Han; Bok-Man Kang; Chi-Woong Mun; Sang-Jae Lee; Seung-Kug Baik
Journal:  J Neurol       Date:  2013-05-14       Impact factor: 4.849

10.  Clinical, cognitive, and behavioural correlates of white matter damage in progressive supranuclear palsy.

Authors:  Federica Agosta; Sebastiano Galantucci; Marina Svetel; Milica Ječmenica Lukić; Massimiliano Copetti; Kristina Davidovic; Aleksandra Tomić; Edoardo G Spinelli; Vladimir S Kostić; Massimo Filippi
Journal:  J Neurol       Date:  2014-03-06       Impact factor: 4.849

View more
  14 in total

1.  Track density imaging in progressive supranuclear palsy: A pilot study.

Authors:  Salvatore Nigro; Maria Giovanna Bianco; Gennarina Arabia; Maurizio Morelli; Rita Nisticò; Fabiana Novellino; Maria Salsone; Antonio Augimeri; Aldo Quattrone
Journal:  Hum Brain Mapp       Date:  2018-11-26       Impact factor: 5.038

2.  MRI gray and white matter measures in progressive supranuclear palsy and corticobasal syndrome.

Authors:  Neeraj Upadhyay; Antonio Suppa; Maria Cristina Piattella; Matteo Bologna; Flavio Di Stasio; Alessandra Formica; Francesca Tona; Carlo Colosimo; Alfredo Berardelli; Patrizia Pantano
Journal:  J Neurol       Date:  2016-07-13       Impact factor: 4.849

3.  Multimodal MRI evaluation of parkinsonian limbic pathologies.

Authors:  Ernest W Wang; Guangwei Du; Mechelle M Lewis; Eun-Young Lee; Sol De Jesus; Sangam Kanekar; Lan Kong; Xuemei Huang
Journal:  Neurobiol Aging       Date:  2019-01-16       Impact factor: 4.673

4.  Dentatorubrothalamic tract reduction using fixel-based analysis in corticobasal syndrome.

Authors:  Shun Sakamoto; Takashi Kimura; Koji Kajiyama; Kumiko Ando; Masanaka Takeda; Hiroo Yoshikawa
Journal:  Neuroradiology       Date:  2020-09-29       Impact factor: 2.804

5.  Topographic distribution of white matter changes and lacunar infarcts in neurodegenerative and vascular dementia syndromes: A post-mortem 7.0-tesla magnetic resonance imaging study.

Authors:  Jacques De Reuck; Florent Auger; Nicolas Durieux; Charlotte Cordonnier; Vincent Deramecourt; Florence Pasquier; Claude-Alain Maurage; Didier Leys; Regis Bordet
Journal:  Eur Stroke J       Date:  2016-05-18

Review 6.  Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?

Authors:  Jennifer L Whitwell; Günter U Höglinger; Angelo Antonini; Yvette Bordelon; Adam L Boxer; Carlo Colosimo; Thilo van Eimeren; Lawrence I Golbe; Jan Kassubek; Carolin Kurz; Irene Litvan; Alexander Pantelyat; Gil Rabinovici; Gesine Respondek; Axel Rominger; James B Rowe; Maria Stamelou; Keith A Josephs
Journal:  Mov Disord       Date:  2017-05-13       Impact factor: 10.338

7.  Abnormal Resting-State Functional Connectivity in Progressive Supranuclear Palsy and Corticobasal Syndrome.

Authors:  Komal Bharti; Matteo Bologna; Neeraj Upadhyay; Maria Cristina Piattella; Antonio Suppa; Nikolaos Petsas; Costanza Giannì; Francesca Tona; Alfredo Berardelli; Patrizia Pantano
Journal:  Front Neurol       Date:  2017-06-06       Impact factor: 4.003

8.  Alterations of Diffusion Kurtosis and Neurite Density Measures in Deep Grey Matter and White Matter in Parkinson's Disease.

Authors:  Yulia Surova; Björn Lampinen; Markus Nilsson; Jimmy Lätt; Sara Hall; Håkan Widner; Danielle van Westen; Oskar Hansson
Journal:  PLoS One       Date:  2016-06-30       Impact factor: 3.240

9.  Prospective Characterization of Cognitive Function in Typical and 'Brainstem Predominant'Progressive Supranuclear Palsy Phenotypes.

Authors:  Young-Eun C Lee; David R Williams; Jacqueline F I Anderson
Journal:  J Mov Disord       Date:  2018-05-30

10.  Brain gray matter abnormalities in progressive supranuclear palsy revisited.

Authors:  PingLei Pan; Yi Liu; Yang Zhang; Hui Zhao; Xing Ye; Yun Xu
Journal:  Oncotarget       Date:  2017-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.